SimpleScreen CRC Blood Test Cleared by FDA for Average-Risk Adults
The FDA has cleared Freenome's SimpleScreen CRC blood test. It is a new screening option for average-risk adults. The ap…
Read full reportSale on Manual & Electric Hospital Beds - Starting from 25 September!
News tagged “Healthcare”.
The FDA has cleared Freenome's SimpleScreen CRC blood test. It is a new screening option for average-risk adults. The ap…
Rebecca Miles 145 views
New TESLA trial thrombectomy data show a 1-year benefit for large-core acute ischemic stroke patients. That holds even t…
Read more
New ACP obesity guidelines name semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) as first-line drugs. …
Read more
A new hantavirus cruise ship outbreak on the MV Hondius has hit 13 cases and 3 deaths as of May 27, 2026. Labs confirmed…
Read more
A new look at GLP-1 oral side effects shows "Ozempic mouth" is more than a tabloid label. Dentists track dry mouth, hali…
Read more
A new psilocybin dementia case from Brazil describes major symptom relief in an 80-year-old woman with advanced Alzheime…
Read more
A new ER-100 epigenetic therapy from Life Biosciences has reached its first human patient. The Boston-based biotech has …
Read more
A new look at BPH herbal remedies finds that plant-based options ease mild LUTS. But gains stay modest. Evidence stays p…
Read more
A new HDV-LIS T1D trial readout from OPTI-2 shows a liver-targeted fast-acting insulin cut hypoglycemia risk in type 1 d…
Read more
A new bimekizumab PsA trial readout from BE BOLD shows dual IL-17A/IL-17F inhibition (bimekizumab, Bimzelx) beats IL-23 …
Read more
A new CGM type 2 diabetes readout from the CONNECT trial shows continuous glucose monitoring cuts A1c more than standard…
Read more
A new proton therapy prostate readout from the large COMPPARE study suggests the two modern radiotherapy options produce…
Read more
A new fenebrutinib MS trial may be the first win for BTK inhibitors (BTKis) in multiple sclerosis (MS). The oral drug be…
Read more